Warren Buffett Trims Apple Stake, Portfolio Shake-upby Mark Eisenberg 17.02.2024Berkshire Hathaway, led by Warren Buffett, sells a small portion of Apple shares amid portfolio adjustments. However, it still holds ...
2024 Fed Rate Cuts: Unlikely Outcome Forecastby Terry Bingman 17.02.2024Experts suggest that there is a nonconsensus outlook for no rate cuts in 2024, despite market predictions. The market is ...
Trump Slapped With $355M Fraud Verdict: Major Blow to Wealth and Imageby Mark Eisenberg 17.02.2024A New York judge orders Donald Trump and his companies to pay $355 million for financial fraud, dealing a blow ...
Cash App Under Federal Investigation: Money Laundering Allegationsby Mark Eisenberg 17.02.2024Federal financial regulators are investigating allegations that Cash App neglected to conduct proper due diligence, potentially facilitating money laundering and ...
Bank of America Triumphs Over Competitorsby Mark Eisenberg 17.02.2024Bank of America Corp. leads competitors, showing resilience in a lackluster market. Despite lower trading volume, the stock gains and ...
LPL Financial’s Acquisition of Atria: Game-Changing Wealth Merger.by Terry Bingman 17.02.2024LPL Financial's acquisition of Atria Wealth Solutions is expected to increase its reach and earnings, boosting its share price and ...
Crypto Funding Surge: End of Winter in Sight?by John Darbie 17.02.2024Venture capital funding for crypto firms has increased for the first time since early 2022, signaling a possible end to ...
Revolut Launches New Crypto Exchange for Advanced Tradersby John Darbie 16.02.2024Digital bank Revolut has launched a beta version of its cryptocurrency exchange, designed for advanced traders. The exchange offers lower ...
Bugcrowd Leads Fintech Surge with $102M Raiseby Lilu Anderson 16.02.2024Bugcrowd secured an impressive $102 million in Series E funding, reflecting the rising demand for cybersecurity solutions to combat cyber ...
Cellebrite Stock Upgraded by BofA: Buy Now!by Mark Eisenberg 16.02.2024Bank of America Securities upgrades Cellebrite stock to Buy, increasing price target to $12. Improved business momentum and strong market ...